Clinical dividends from the molecular genetic diagnosis of craniosynostosis
✍ Scribed by Andrew O.M. Wilkie; Elena G. Bochukova; Ruth M. S. Hansen; Indira B. Taylor; Sahan V. Rannan-Eliya; Jo C. Byren; Steven A. Wall; Lina Ramos; Margarida Venâncio; Jane A. Hurst; Anthony W. O'Rourke; Louise J. Williams; Anneke Seller; Tracy Lester
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 234 KB
- Volume
- 140A
- Category
- Article
- ISSN
- 1552-4825
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Medicine is undergoing a quiet revolution. Molecular genetics is transforming clinical science and practice; the development of the Human Genome Project allows new methods of disease identification and of predicting disease patterns for individual patients. Knowledge of the human genome will deepen
We describe an individual in whom molecular genetic testing provided a diagnosis of the Carney complex, an autosomal dominant syndrome comprising cutaneous and cardiac myxomas, spotty pigmentation of the skin, and endocrinopathy. Recently, we localized the Carney complex disease gene to chromosome r
Hereditary cancer represents approximately 5-10% of the total cancer burden and may account for 60,000 to 120,000 new cancer occurrences this year in the United States. New developments in molecular genetics and the cloning of cancer-prone genes have intensely fueled interest in dealing with heredit
Autosomal recessive polycystic kidney disease (ARPKD) is one of the most common hereditary renal cystic diseases and has a high infant mortality. Prenatal diagnosis using fetal sonography can be unreliable, especially in early pregnancy. The ARPKD locus has been mapped to proximal chromosome 6p allo